DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Chlorogenic Acid is an investigational drug.
There have been 7 clinical trials for Chlorogenic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on November 27th 2018.
The most common disease conditions in clinical trials are Neoplasms, Glucose Intolerance, and Lung Neoplasms. The leading clinical trial sponsors are Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd, Chinese Academy of Medical Sciences, and Cancer Institute and Hospital, Chinese Academy of Medical Sciences.
There is one US patent protecting this investigational drug and ten international patents.
Recent Clinical Trials for Chlorogenic Acid
|Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients||Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd||Phase 2/Phase 3|
|Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer||Cancer Institute and Hospital, Chinese Academy of Medical Sciences||Phase 1/Phase 2|
|Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer||Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd||Phase 1/Phase 2|
Top disease conditions for Chlorogenic Acid
Top clinical trial sponsors for Chlorogenic Acid
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Chlorogenic Acid||See Pricing||Granulation of a stevia sweetener||PureCircle Sdn Bhd (Kuala Lumpur, MY)||See Pricing|
|Chlorogenic Acid||See Pricing||Methods and compositions for treating infection||UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)||See Pricing|
|Chlorogenic Acid||See Pricing||Uses of chlorogenic acid in the preparation of medicaments for treatment of oligodendroglioma||SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD. (Chengdu, Sichuan, CN)||See Pricing|
|Chlorogenic Acid||See Pricing||Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid||L'OREAL (Paris, FR)||See Pricing|
|Chlorogenic Acid||See Pricing||Matrix and layer compositions for protection of bioactives||Novus International, Inc. (St. Charles, MO)||See Pricing|
|Chlorogenic Acid||See Pricing||Method for regulating retinal endothelial cell viability||The University of Tennessee Research Foundation (Memphis, TN)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Chlorogenic Acid||Brazil||112012011382||2029-11-12||See Pricing|
|Chlorogenic Acid||Canada||2780561||2029-11-12||See Pricing|
|Chlorogenic Acid||European Patent Office||2498625||2029-11-12||See Pricing|
|Chlorogenic Acid||European Patent Office||3461342||2029-11-12||See Pricing|
|Chlorogenic Acid||Spain||2707280||2029-11-12||See Pricing|
|Chlorogenic Acid||Mexico||2012005608||2029-11-12||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|